Disaggregated Revenues (Tables)

3 Months Ended

Mar. 31, 2023

Disaggregation of Revenue [Abstract]

Summary of disaggregation of revenues by nature

The following table summarizes the disaggregation of revenues by product or source, (dollars in thousands):

	Three Months Ended March 31,
	2023		2022
	(unaudited)
Net product sales
Trokendi XR	$	34,790	$	62,832
Oxtellar XR	28,915		27,521
GOCOVRI	26,010		22,601
Qelbree	25,782		8,283
APOKYN	17,209		18,448
Other(1)	7,869		7,779
Total net product sales	$	140,575	$	147,464
Royalty revenues	13,189		5,042
Total revenues	$	153,764	$	152,506

___________________________________________

(1) Includes net product sales of MYOBLOC, XADAGO and Osmolex ER.